• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Cyclical·KAYA.NS
Share

Kaya Limited Stocks

₹ 318.75Last Updated 16.10.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 50.98M

₹ 318.75
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Kaya Limited manages and operates a network of specialized clinics focused on dermatological and trichological well-being. The company delivers a wide spectrum of treatments addressing issues such as age-related skin concerns, pigmentation irregularities, acne and scar management, permanent laser hair reduction, hair loss prevention, surgical hair restoration, and solutions for dandruff or under-nourished hair. Additionally, it provides various aesthetic improvement services. Beyond its clinical offerings, Kaya also manufactures and distributes a diverse collection of hair and skin care products tailored for both men and women. These products are retailed through Kaya's own brand stores, numerous online platforms, third-party vendors, and its dedicated e-commerce site, shop.kaya.in. The company's operational footprint encompasses 71 clinics throughout India and an additional 23 establishments situated in the Middle East. Established in 2002, Kaya Limited is headquartered in Mumbai, India.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, undervalued on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.10.2026 16:08

Morning in New York: Looking for a Foothold Ahead of Tech Giants' Earnings Reports

19.10.2026 15:56

After the elections, French markets face a more serious test—the City. What should investors do?

19.10.2026 15:19

An analyst has identified a new driver for Victoria's Secret's stock: weight-loss products

19.10.2026 14:45

Fears surrounding AI are bringing treasury back into a defensive role. What should investors be prepared for?

19.10.2026 14:11

Musk promised to give SpaceX stock to “every child in America”

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026